Webinar. Hydromorphone for Opioid Use Disorder: Insights from the Feasibility of Opioid Injecting Trial

Penington Institute invites you to join us for a discussion featuring an expert panel on the trial of short-acting injectable opioid treatment – IV hydromorphone.

Supervised Injectable Opioid Treatment is a proven intervention designed for individuals with opioid dependence when conventional treatments have not been effective. Research highlights its success in reducing illicit opioid use, curbing crime rates, and enhancing overall health and wellbeing.

Despite its benefits, injectable hydromorphone treatment remains a topic of controversy.

Uniting NSW. ACT, UNSW, and St Vincent’s Hospital Sydney, partnered on this initiative to evaluate the acceptability of injectable hydromorphone within an Australian context.

Do the results pave the way for a significant shift? Our expert panel will discuss various aspects of the trial, including its unique features, feasibility challenges, and potential pathways for future expansion. 

Date & Time: Date: Wed. 03 Apr 2024, Start Time: 01:00 pm, End Time: 02:00 pm 

Datum & Uhrzeit: 3.Apr. 2024 04:00 AM in Amsterdam, Berlin, Rom, Stockholm, Wien

https://us02web.zoom.us/webinar/register/WN_ub4xmxg5RN6kV3SGaQhI6w#/registration